A 2019 TOP DOC
Dr. Neil Friedman, Director of The Hoffberger Breast Center is one of the most respected breast cancer surgeons in the Baltimore area. He has focused his career on improving treatment options for women with breast cancer.
Inflammatory bowel disease, or IBD, includes disorders that cause inflammation of the intestines. IBD is treated at Mercy by expert gastroenterologists.
Our Center offers physician expertise with a dedication to advancing services and treatments for neurological disorders and neuromuscular diseases.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Dr. Paul Thuluvath, Dr. Anurag Maheshwari and Dr. Hwan Yoo are recognized experts for diagnosing and treating biliary diseases, including the primary types of biliary cancer: hepatocellular carcinoma and cholangiocarcinoma. Patients turn to the doctors at The Center for Liver and Hepatobiliary Diseases at Mercy in Baltimore for their innovative treatment options.
Cholangiocarcinoma, also referred to as bile duct cancer, is a rare form of cancer that affects the tissue in the bile ducts, which carry bile from the liver to the small intestine. Bile duct cancer is slow growing and does not spread quickly. Once bile duct cancer symptoms appear and a diagnosis is made, the tumor may be too advanced for surgery.
Cholangiocarcinoma symptoms occur when the tumor blocks the bile duct, prohibiting the bile to freely flow. Bile duct cancer symptoms include:
Patients with primary sclerosing cholangitis, ulcerative colitis, bile duct cysts, or chronic biliary inflammation are at a higher risk to develop cholangiocarcinoma.
A physical examination as well as tests can be performed to detect bile duct tumors. Common tests for cholangiocarcinoma include:
By the time cholangiocarcinoma is diagnosed, the cancer often has spread. When possible, the surgical removal of the tumor in the bile duct is the preferred treatment option for cholangiocarcinoma. A liver transplant may be a treatment option if the bile duct tumor is too large to remove. When surgery is not a cholangiocarcinoma treatment option, other treatments are available, including radiation therapy, chemotherapy, photodynamic therapy, and biliary drainage with palliative endoscopically placed biliary stents to improve quality of life.
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
Dr. Richard Desi of The Institute for Digestive Health and Liver Disease, focuses on hepatology, a sub-specialty of gastroenterology that addresses the liver, gallbladder, pancreas and biliary tract.
When cancer runs in your family, it is hard to avoid. Certain foods, supplements and a balanced diet may help reduce your risks.